Adverse event/effect(s): 12b. Specific: fatigue: ii. average scores (FSS, endpoint, high = poor, skewed data) | ||||||
---|---|---|---|---|---|---|
Study | Mean (Modafinil group) | SD (Modafinil group) | N (Modafinil Group) | Mean (Placebo group) | SD (Placebo group) | N (Placebo group) |
Sevy 2005 | 32.3 | 7.2 | 10 | 34.9 | 14.2 | 10 |